| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ACOXL
|
acyl-CoA oxidase-like
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APOE
|
apolipoprotein E
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKB
|
aurora kinase B
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BID
|
BH3 interacting domain death agonist
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
CAPN2
|
calpain 2, (m/II) large subunit
|
|
CAPN3
|
calpain 3, (p94)
|
|
CAPN9
|
calpain 9
|
|
CARD8
|
caspase recruitment domain family, member 8
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP2
|
caspase 2, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP5
|
caspase 5, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL27
|
chemokine (C-C motif) ligand 27
|
|
CCND1
|
cyclin D1
|
|
CCNH
|
cyclin H
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD28
|
CD28 molecule
|
|
CD38
|
CD38 molecule
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC45
|
cell division cycle 45
|
|
CDC6
|
cell division cycle 6
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CENPF
|
centromere protein F, 350/400kDa
|
|
CPEB1
|
cytoplasmic polyadenylation element binding protein 1
|
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle)
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C18
|
cytochrome P450, family 2, subfamily C, polypeptide 18
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP4B1
|
cytochrome P450, family 4, subfamily B, polypeptide 1
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DISC1
|
disrupted in schizophrenia 1
|
|
E2F2
|
E2F transcription factor 2
|
|
EDN1
|
endothelin 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC4
|
excision repair cross-complementation group 4
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERCC6
|
excision repair cross-complementation group 6
|
|
ESCO1
|
establishment of sister chromatid cohesion N-acetyltransferase 1
|
|
ESCO2
|
establishment of sister chromatid cohesion N-acetyltransferase 2
|
|
EXO1
|
exonuclease 1
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FADD
|
Fas (TNFRSF6)-associated via death domain
|
|
FARP2
|
FERM, RhoGEF and pleckstrin domain protein 2
|
|
FGF4
|
fibroblast growth factor 4
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAS
|
GNAS complex locus
|
|
GSTA2
|
glutathione S-transferase alpha 2
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
HFE
|
hemochromatosis
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HSPA6
|
heat shock 70kDa protein 6 (HSP70B')
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
IFNG
|
interferon, gamma
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGH
|
immunoglobulin heavy locus
|
|
IL10
|
interleukin 10
|
|
IL12A
|
interleukin 12A
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL13
|
interleukin 13
|
|
IL16
|
interleukin 16
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL3
|
interleukin 3
|
|
IL33R
|
interleukin 33 receptor
|
|
IL36R
|
interleukin 36 receptor
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5RA
|
interleukin 5 receptor, alpha
|
|
IL6
|
interleukin 6
|
|
IL6ST
|
interleukin 6 signal transducer
|
|
IRAK4
|
interleukin-1 receptor-associated kinase 4
|
|
IRF4
|
interferon regulatory factor 4
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)
|
|
ITGAE
|
integrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)
|
|
ITGB4
|
integrin, beta 4
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LTA
|
lymphotoxin alpha
|
|
MCM4
|
minichromosome maintenance complex component 4
|
|
MCM5
|
minichromosome maintenance complex component 5
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP8
|
matrix metallopeptidase 8
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MSH2
|
mutS homolog 2
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
N4BP1
|
NEDD4 binding protein 1
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NBN
|
nibrin
|
|
NLRP1
|
NLR family, pyrin domain containing 1
|
|
NLRP11
|
NLR family, pyrin domain containing 11
|
|
NLRP13
|
NLR family, pyrin domain containing 13
|
|
NLRP14
|
NLR family, pyrin domain containing 14
|
|
NLRP2
|
NLR family, pyrin domain containing 2
|
|
NLRP4
|
NLR family, pyrin domain containing 4
|
|
NLRP5
|
NLR family, pyrin domain containing 5
|
|
NLRP8
|
NLR family, pyrin domain containing 8
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
OPRM1
|
opioid receptor, mu 1
|
|
ORC3
|
origin recognition complex, subunit 3
|
|
ORC4
|
origin recognition complex, subunit 4
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PML
|
promyelocytic leukemia
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLL
|
polymerase (DNA directed), lambda
|
|
PPP2R5E
|
protein phosphatase 2, regulatory subunit B', epsilon isoform
|
|
PRKD2
|
protein kinase D2
|
|
PRKDC
|
protein kinase, DNA-activated, catalytic polypeptide
|
|
PTCH1
|
patched 1
|
|
RAD1
|
RAD1 checkpoint DNA exonuclease
|
|
RAD21
|
RAD21 homolog (S. pombe)
|
|
RAD23B
|
RAD23 homolog B (S. cerevisiae)
|
|
RAD51
|
RAD51 recombinase
|
|
RAG1
|
recombination activating gene 1
|
|
RAP1GAP
|
RAP1 GTPase activating protein
|
|
RBL2
|
retinoblastoma-like 2
|
|
RCAN1
|
regulator of calcineurin 1
|
|
RCAN3
|
RCAN family member 3
|
|
REV1
|
REV1, polymerase (DNA directed)
|
|
REV3L
|
REV3-like, polymerase (DNA directed), zeta, catalytic subunit
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SELPLG
|
selectin P ligand
|
|
SLC28A1
|
solute carrier family 28 (concentrative nucleoside transporter), member 1
|
|
SLC28A2
|
solute carrier family 28 (concentrative nucleoside transporter), member 2
|
|
SLC28A3
|
solute carrier family 28 (concentrative nucleoside transporter), member 3
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SP110
|
SP110 nuclear body protein
|
|
SP140
|
SP140 nuclear body protein
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP53BP1
|
tumor protein p53 binding protein 1
|
|
TP73
|
tumor protein p73
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
XCL1
|
chemokine (C motif) ligand 1
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC2
|
X-ray repair complementing defective repair in Chinese hamster cells 2
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
XRCC5
|
X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)
|
|
XRCC6
|
X-ray repair complementing defective repair in Chinese hamster cells 6
|
